| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 吡啶类(元) | 196,538,788.24 | 393,429,083.62 | 214,055,795.67 | 320,754,319.01 | 184,732,240.68 |
| 非吡啶类(元) | 26,001,386.07 | 49,578,872.88 | 30,172,838.94 | 52,439,428.13 | 26,645,079.53 |
| 营业成本(元) | |||||
| 吡啶类(元) | 171,903,640.37 | 362,497,959.19 | 201,162,622.57 | 290,102,139.30 | - |
| 非吡啶类(元) | 21,943,618.90 | 38,686,441.48 | 23,345,993.19 | 36,816,893.14 | - |
| 毛利(元) | |||||
| 吡啶类(元) | 24,635,147.87 | 30,931,124.43 | 12,893,173.10 | 30,652,179.71 | - |
| 非吡啶类(元) | 4,057,767.17 | 10,892,431.40 | 6,826,845.75 | 15,622,534.99 | - |
| 毛利率(%) | |||||
| 吡啶类(%) | 12.53 | 7.86 | 6.02 | 9.56 | - |
| 非吡啶类(%) | 15.61 | 21.97 | 22.63 | 29.79 | - |
| 收入构成(%) | |||||
| 吡啶类(%) | 88.32 | 88.81 | 87.65 | 85.95 | 87.39 |
| 非吡啶类(%) | 11.68 | 11.19 | 12.35 | 14.05 | 12.61 |
| 毛利构成(%) | |||||
| 吡啶类(%) | 85.86 | 73.96 | 65.38 | 66.24 | - |
| 非吡啶类(%) | 14.14 | 26.04 | 34.62 | 33.76 | - |
